TFS Capital’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-22,599
| Closed | -$886K | – | 842 |
|
2017
Q1 | $886K | Buy |
+22,599
| New | +$886K | 0.29% | 113 |
|
2016
Q3 | – | Sell |
-27,071
| Closed | -$639K | – | 1093 |
|
2016
Q2 | $639K | Buy |
27,071
+2,834
| +12% | +$66.9K | 0.12% | 311 |
|
2016
Q1 | $494K | Buy |
+24,237
| New | +$494K | 0.07% | 448 |
|
2015
Q1 | – | Sell |
-50,016
| Closed | -$1.42M | – | 1206 |
|
2014
Q4 | $1.42M | Buy |
50,016
+38,784
| +345% | +$1.1M | 0.14% | 223 |
|
2014
Q3 | $284K | Sell |
11,232
-65,839
| -85% | -$1.66M | 0.02% | 762 |
|
2014
Q2 | $2.25M | Buy |
77,071
+35,485
| +85% | +$1.04M | 0.18% | 158 |
|
2014
Q1 | $1.08M | Buy |
41,586
+7,117
| +21% | +$184K | 0.07% | 423 |
|
2013
Q4 | $888K | Buy |
34,469
+1,440
| +4% | +$37.1K | 0.04% | 593 |
|
2013
Q3 | $884K | Buy |
33,029
+23,943
| +264% | +$641K | 0.04% | 628 |
|
2013
Q2 | $223K | Buy |
+9,086
| New | +$223K | 0.01% | 1281 |
|